TCI Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Buy
15,257
+98
+0.6% +$2.56K 0.02% 184
2026
Q1
$426K Sell
15,159
-717
-5% -$19.1K 0.02% 159
2025
Q4
$395K Sell
15,876
-34
-0.2% -$857 0.02% 167
2025
Q3
$405K Sell
15,910
-1,740
-10% -$42.9K 0.02% 169
2025
Q2
$428K Sell
17,650
-1,042
-6% -$24.3K 0.03% 156
2025
Q1
$474K Sell
18,692
-1,014
-5% -$26.5K 0.04% 131
2024
Q4
$523K Buy
19,706
+4,506
+30% +$122K 0.04% 120
2024
Q3
$440K Buy
15,200
+570
+4% +$16.6K 0.04% 146
2024
Q2
$409K Buy
14,630
+805
+6% +$22.2K 0.04% 139
2024
Q1
$384K Sell
13,825
-1,402
-9% -$38.9K 0.04% 143
2023
Q4
$438K Buy
15,227
+682
+5% +$20.6K 0.05% 128
2023
Q3
$482K Sell
14,545
-2,331
-14% -$82.4K 0.06% 110
2023
Q2
$619K Buy
16,876
+28
+0.2% +$1.09K 0.08% 98
2023
Q1
$687K Sell
16,848
-4,082
-20% -$176K 0.09% 87
2022
Q4
$1.07M Buy
20,930
+395
+2% +$18.9K 0.15% 60
2022
Q3
$899K Sell
20,535
-66
-0.3% -$3.21K 0.15% 63
2022
Q2
$1.08M Buy
20,601
+1,539
+8% +$78.4K 0.17% 59
2022
Q1
$987K Buy
19,062
+1,513
+9% +$78.5K 0.15% 66
2021
Q4
$1.04M Sell
17,549
-1,665
-9% -$82.5K 0.15% 64
2021
Q3
$826K Buy
19,214
+1,388
+8% +$61.5K 0.13% 78
2021
Q2
$698K Sell
17,826
-1,983
-10% -$77.1K 0.12% 87
2021
Q1
$718K Sell
19,809
-409
-2% -$14.5K 0.3% 72
2020
Q4
$744K Sell
20,218
-49,126
-71% -$1.8M 0.33% 69
2020
Q3
$2.42M Sell
69,344
-1,269
-2% -$44.5K 0.95% 19
2020
Q2
$2.19M Buy
70,613
+358
+0.5% +$12.2K 0.94% 24
2020
Q1
$2.18M Sell
70,255
-1,747
-2% -$59.5K 1.07% 20
2019
Q4
$2.68M Buy
72,002
+75
+0.1% +$2.67K 1.04% 16
2019
Q3
$2.45M Sell
71,927
-576
-0.8% -$20.9K 1.09% 18
2019
Q2
$2.98M Sell
72,503
-820
-1% -$32.6K 1.34% 15
2019
Q1
$2.95M Buy
73,323
+258
+0.4% +$10.3K 1.3% 17
2018
Q4
$3.03M Buy
73,065
+14
+0% +$581 1.47% 14
2018
Q3
$3.05M Sell
73,051
-978
-1% -$37.6K 1.28% 17
2018
Q2
$2.55M Buy
74,029
+263
+0.4% +$8.99K 1.13% 19
2018
Q1
$2.48M Sell
73,766
-1,367
-2% -$47K 1.15% 19
2017
Q4
$2.58M Buy
75,133
+1,449
+2% +$49.4K 1.13% 18
2017
Q3
$2.5M Buy
73,684
+110
+0.1% +$3.54K 1.22% 18
2017
Q2
$2.35M Buy
73,574
+50
+0.1% +$1.58K 1.2% 19
2017
Q1
$2.39M Buy
73,524
+1,048
+1% +$33K 1.24% 20
2016
Q4
$2.23M Buy
72,476
+370
+0.5% +$11.3K 1.17% 20
2016
Q3
$2.32M Sell
72,106
-204
-0.3% -$6.82K 1.26% 19
2016
Q2
$2.42M Sell
72,310
-1,678
-2% -$53.6K 1.34% 20
2016
Q1
$2.08M Sell
73,988
-2,354
-3% -$67.2K 1.15% 21
2015
Q4
$2.34M Sell
76,342
-264
-0.3% -$8.3K 1.3% 18
2015
Q3
$2.28M Buy
76,606
+2,413
+3% +$77.4K 1.38% 16
2015
Q2
$2.36M Buy
74,193
+896
+1% +$29.2K 1.35% 17
2015
Q1
$2.42M Buy
73,297
+3,529
+5% +$112K 1.52% 15
2014
Q4
$2.06M Buy
69,768
+1,242
+2% +$35.6K 1.28% 17
2014
Q3
$1.92M Buy
68,526
+1,570
+2% +$44.1K 1.21% 21
2014
Q2
$1.89M Sell
66,956
-206
-0.3% -$5.87K 1.13% 22
2014
Q1
$2.05M Sell
67,162
-3,764
-5% -$112K 1.33% 16
2013
Q4
$2.06M Buy
70,926
+3,904
+6% +$114K 1.29% 16
2013
Q3
$1.83M Sell
67,022
-9,830
-13% -$267K 1.39% 14
2013
Q2
$2.04M Buy
+76,852
New +$2.12M 1.55% 12

Other funds holding PFE

TCI Wealth Advisors's PFE Position: Q2 2026 in Review

TCI Wealth Advisors increased its Pfizer (PFE) stake by 0.65% in Q2 2026, buying an estimated $2.56K and bringing the position to 15,257 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #184.

TCI Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.05M in Q3 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TCI Wealth Advisors held 15,257 shares of Pfizer worth $367K as of Q2 2026.
  • TCI Wealth Advisors bought 98 Pfizer shares in Q2 2026, an estimated $2.56K.
  • Pfizer made up 0.02% of TCI Wealth Advisors's portfolio in Q2 2026, its #184 holding.
  • TCI Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • TCI Wealth Advisors's Pfizer position peaked at $3.05M in Q3 2018.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.